|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INFLAMMATION AND IMMUNOPHARMACOLOGY
Bayer Yakuhin, Ltd., Research Center Kyoto, Respiratory Diseases Research, Kyoto, Japan
The recently identified histamine receptor, H4, was shown to be primarily expressed on leukocytes and has been implicated in the activation of lymphocytes, eosinophils, and mast cells in vitro. Its function in vivo, however, has not yet been characterized. We present evidence for a critical role of H4 receptor in the mast cell-dependent recruitment of neutrophils. Mice injected with zymosan into the pleural cavity developed massive neutrophilia within hours after challenge. Neutrophilia was dose-dependently reduced when mice were pretreated with thioperamide, a known H3/4 receptor antagonist, whereas H1 and H2 receptor antagonists lacked efficacy. Similarly, a 70 to 80% reduction in neutrophils in the pleural cavity compared with wild-type animals was noted in mice lacking mast cells (W/Wv mice); mice deficient in MyD88 (MyD88/); a critical component of the signaling cascade of the major receptor for zymosan, toll-like receptor 2 (TLR2); or in mice pretreated with a functionally antagonistic anti-TLR2 antibody. The residual 20% neutrophil infiltration seen in mast cell-deficient and MyD88/ mice was not further reduced by thioperamide. Neutrophilia was completely restored by transferring wild-type bone marrow-derived mast cells into MyD88/ or W/Wv mice. Interestingly, when neutrophilia was evoked by carrageenan injection, mast cell depletion and thioperamide had no effect. Various inflammatory mediators were detectable in the pleural cavity of zymosan-challenged mice. Upon pretreatment with thioperamide, reduced levels of the neutrophil chemattractant leukotriene B4 were observed, providing a mechanistic explanation for the prevention of neutrophilia by H4 receptor antagonism.
Address correspondence to: Dr. F. Gantner, Bayer Yakuhin, Ltd., Research Center Kyoto, Respiratory Diseases Research, 6-5-1-3 Kunimidai, Kizu-cho, Soraku-gun, 619-0216 Kyoto, Japan. E-mail: florian.gantner.fg{at}bayer.co.jp
This article has been cited by other articles:
![]() |
S. Zarini, M. A. Gijon, A. E. Ransome, R. C. Murphy, and A. Sala Transcellular biosynthesis of cysteinyl leukotrienes in vivo during mouse peritoneal inflammation PNAS, May 19, 2009; 106(20): 8296 - 8301. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Sutton, A. Zhao, K. B. Madden, J. E. Elfrey, B. A. Tuft, C. A. Sullivan, J. F. Urban Jr., and T. Shea-Donohue Anti-Inflammatory Mechanisms of Enteric Heligmosomoides polygyrus Infection against Trinitrobenzene Sulfonic Acid-Induced Colitis in a Murine Model Infect. Immun., October 1, 2008; 76(10): 4772 - 4782. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Yuhki, F. Ushikubi, H. Naraba, A. Ueno, H. Kato, F. Kojima, S. Narumiya, Y. Sugimoto, M. Matsushita, and S. Oh-ishi Prostaglandin I2 Plays a Key Role in Zymosan-Induced Mouse Pleurisy J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 601 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Kelly, K. McNagny, D. L. Williams, N. van Rooijen, L. Maxwell, C. Gwozd, C. H. Mody, and P. Kubes The Lung Responds to Zymosan in a Unique Manner Independent of Toll-Like Receptors, Complement, and Dectin-1 Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 227 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Morgan, B. McAllister, L. Cross, D. S. Green, H. Kornfeld, D. M. Center, and W. W. Cruikshank Histamine 4 Receptor Activation Induces Recruitment of FoxP3+ T Cells and Inhibits Allergic Asthma in a Murine Model J. Immunol., June 15, 2007; 178(12): 8081 - 8089. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. van Rijn, P. L. Chazot, F. C. Shenton, K. Sansuk, R. A. Bakker, and R. Leurs Oligomerization of Recombinant and Endogenously Expressed Human Histamine H4 Receptors Mol. Pharmacol., August 1, 2006; 70(2): 604 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
L E Sander, A Lorentz, G Sellge, M Coeffier, M Neipp, T Veres, T Frieling, P N Meier, M P Manns, and S C Bischoff Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract Gut, April 1, 2006; 55(4): 498 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Cailhier, D. A. Sawatzky, T. Kipari, K. Houlberg, D. Walbaum, S. Watson, R. A. Lang, S. Clay, D. Kluth, J. Savill, et al. Resident Pleural Macrophages Are Key Orchestrators of Neutrophil Recruitment in Pleural Inflammation Am. J. Respir. Crit. Care Med., March 1, 2006; 173(5): 540 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Lim, R. M. van Rijn, P. Ling, R. A. Bakker, R. L. Thurmond, and R. Leurs Evaluation of Histamine H1-, H2-, and H3-Receptor Ligands at the Human Histamine H4 Receptor: Identification of 4-Methylhistamine as the First Potent and Selective H4 Receptor Agonist J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1310 - 1321. [Abstract] [Full Text] [PDF] |
||||